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A non-uniform Dose Painting By Numbers Dose Distribution 
(DPBN) was obtained from an ADC map of each patient 
registered with the planning CT scan. The pixels values 
within the CTV of the registered ADC maps were converted to 
dose values through the function of Eq. 1, where Dmin = 25 
Gy, Dmax = 50 Gy, Imin = 500 mm2/s e Imax = 1500 mm2/s. 
According to Deveau et al., (Acta Oncol. 2010) 9 isodose 
levels of the DPBN should be converted into structures in 
order to restrict the number of planning structures in the TPS 
optimization step. Four different methods to select the 
isodose levels were implemented. 
IsoDose Method (IDM). The dose interval prescription is 
divided in 9 equal sub-intervals (Fig. 1.a). In this way the 
sub-intervals are dependent on the dose prescription interval 
only. 
IsoVol Method (IVD). The volume of the CTV structure is 
divided in 9 equal subvolumes (Fig. 1.b). The absolute DVH of 
the DPBN of the CTV allows to associate to each volume value 
(cm^3) a dose value. These are used as the isolevels to be 
converted in structures. 
IsoVD Method (IVDM). An arbitrary function, indicated as 
∆DV, was defined in Eq. 2 where Dmin and Dmax are the 
minimum and maximum prescribed dose, Vmax is the total 
volume of the CTV, Di and Vi are the dose and the volume at 
the point i in the DVH line. Dividing the ∆DV(Di) function in 9 
equi-spaced interval, as in Fig. 1.c, the corresponding dose 
values, from which derive the sub-structure for the 
optimization, were found. 
minQF Method (mQM). Starting from a structure set of 9 
isolevels obtained from DPBN, it is possible to calculate a 
Dose Painting By Contours Dose Distribution (DPBC), assigning 
to each voxel pertaining to the isolevels k a uniform dose of 
value Dk. This method imposes that the Quality Factor (QF), 
in Eq. 3-4 (Vanderstraeten et al., Phys. Med. Biol. 2006), 
between the DPBN and the DPBC be as close as possible to 
zero, using a genetic minimization algorithm (Matlab). 
In order to estimate which method returns the DPBC more 
consistent with the DPBN, the QF and the QVH were 
computed for each method. 
 
 
 
Results 
Comparing the four methods, the results in Table 1 show that 
the mQM provides QF values closest to zero for six patients 
and that only in one patient the IVD is better than the mQM 
only of about 1 %. Also QVHs show lines more about to 1 for 
the mQM. 
 
 
Conclusion: A robust and mathematical method in order to 
select the structure set that better fit a Dose Painting 
distribution was found in the mQM method. This method 
could be employed regardless the way used to obtained the 
Dose Painting distribution. 
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Purpose or Objective: Brain metastases occur in 20–40 % of 
patients affected by primary solid tumors. Radiosurgery (SRS) 
was demonstrated to be safe and efficient for the brain 
metastases control. SRS can be delivered with dedicated 
equipment, like GammaKnife, or with conventional LINAC. 
Few comparative studies have been conducted. In our 
institution we designed a phase III randomized trial to 
evaluate cerebral side effects following SRS delivered by 
Gamma Knife Perfexion and Linac EDGE 
 
Material and Methods: Patients with 1 to 4 brain metastases, 
from any primary except for small cell lung cancer (SCLC) or 
Lymphoproliferative disease, suitable for SRS were 
randomized to receive the treatment with GammaKnife or 
Linac. Primary end point was the symptomatic radionecrosis 
incidence; brain LC, DFS and OS were secondary end points. 
Planning parameters, including target coverage for accepted 
surface dose levels, paddick conformity index (PCI), gradient 
index (GI), homogeneity index (HI), maximum and minimum 
dose to the target were determined. Beam on time (BOT) was 
also recorded 
 
Results: Until now, 26 patients with 39 metastases (range 1-
3) were enrolled in this phase III trial (12 GK, 14 Linac-EDGE). 
Median prescribed dose was 24 GY (range 21-24 Gy). Most 
common primary cancers were breast and melanoma. At the 
time of analysis 3 patients died. Follow up evaluation was 
available in 12 cases. No local progression was observed, 4 
patients had a further intracranial progression. Until now, no 
radionecrosis was recorded. PCI was better for linac-based 
plans (0.93 vs 0.82), in contrast, a better GI for gamma knife 
was observed (2.5 vs 3.5). Due to the specific characteristics 
of the two delivery systems, HI was lower for linac (0.14 vs 
0.80). BOT was lower for linacs (within 2 min for each target 
vs 35 min). In our center, linac based immobilization was 
made by an open mask setup (qfix); CBCT-based IGRT was 
applied; patients were monitored by optical surface 
monitoring system (OSMS) during the delivery. Gamma knife 
immobilization was performed by the traditional stereotactic 
head frame by Elekta. For this reason, no specific online 
imaging or tracking device was required 
 
Conclusion: These are very preliminary results of a 
randomized phase III trial recently started in our institution. 
No significant clinical data can be provided yet, because of 
the short follow up time and the small number of enrolled 
patients. On the dosimetry side, the two systems have 
different characteristics and markedly different ways to 
prescribe dose. For linacs, a better dose distribution was 
obtained on the target rather than for normal tissues, even 
though no specific side effects were reported. In addition, 
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data suggested a better comfort for the patient for linac-
based therapy, due to the shorter treatment time and the 
non-invasive immobilization system. Dosimetric data for the 
patients treated according to this protocol suggest a 
substantial balance between Gamma Knife and Linac EDGE 
treatments 
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Purpose or Objective: By pooling data of five large 
prospective studies/Institutional series, a large data base of 
pT2-pT3, pN0 patients treated either in the adjuvant or in 
the salvage setting with conventionally fractionated (1.8-2.0 
Gy/fr) 3DCRT post-prostatectomy radiotherapy (RT) was 
available. The aim of the study was to fit individual data of 
biochemical-recurrence-free survival (bRFS) with a 
comprehensive Poisson-based TCP model. 
 
Material and Methods: Considering pre-RT PSA as a surrogate 
of the number of clonogens, 5-year bRFS was expressed as a 
function of the dose depending on radiosensitivity (α_eff), 
number of clonogens for pre-RT PSA=1ng/mL (C) and the 
fraction of patients that relapses due to clonogens outside 
the treated volume, assumed to linearly depend on pre-RT 
PSA (K=1-BxPSA), according to:  
bRFS = (1-B x PSA) x [1 - exp (-α_eff D)]^CxPSA.  
In addition, the impact of Gleason score (GS) was included by 
performing separate fits for different sub-groups, depending 
on GS (<7,=7,>7). In total, complete data regarding bRFS, 
dose, pre-RT PSA (between 0.01 and 2.0 ng/ml) and GS of 
894 hormono-naive patients treated with adjuvant (n=331) or 
salvage (n=563) intent with a minimum follow-up of 3 years 
were available. Patients with GS<7, =7 and >7 were 392, 383, 
and 119 respectively. Best-fit procedures were performed 
with the sequential quadratic programming, using the sum of 
the squared residuals error as loss function (SPSS v.17, SPSS 
Inc., Chicago, IL). The 95% CI of the parameter’s best-fit 
values were calculated by bootstrap. The performance of the 
resulting model was assessed by calibration plot. 
 
Results: The median follow-up was 72 months; median pre-
RT PSA and dose were 0.25 ng/mL (inter-quartile range: 0.1-
0.5) and 66.6Gy (range:59.4-77.4Gy) respectively. The fit 
converged in all situations: depending on GS, best-fit values 
were in the range 0.20-0.22 Gy-1 and 10^6 for α_eff and C 
respectively; the maximum obtainable bRFS was reduced by 
1.7, 4.9 and 5.6% for each 0.1ng/ml PSA increment for GS<7, 
=7 and >7 respectively. The calibration plot showed an 
excellent agreement between predicted and expected values 
(R2=0.96) and the AUC was 0.69 (95% CI: 0.66-0.73). The 
bRFS curves as estimated by the model vs prescribed dose for 
different pre-RT PSA (between 0.1 and 1.0 ng/ml) and for the 
three GS groups are plotted in the figure. 
 
 
Conclusion: Long-term bRFS data of a large multi-centric 
data base of post-prostatectomy patients could be fitted by a 
radiobiologically consistent TCP model, showing a dose-effect 
critically depending on pre-RT PSA and GS. The model 
suggests that most relapses occur in patients with clonogens 
outside the treated volume, indirectly supporting lymph-
nodal irradiation and/or systemic therapy for specific risk 
groups, depending on pre-RT PSA and GS. Early RT is 
preferred over delayed RT as the detrimental effect due to a 
PSA increase can never be compensated by increasing the 
dose, more dramatically evident for patients with GS ≥7. 
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Purpose or Objective: Traditional normal tissue complication 
probability (NTCP) models rely on dose-volume histogram 
(DVH) analysis, which disregards any spatial dose distribution 
information and possible inhomogeneity in regional organ 
radio-sensitivity. We propose a voxel-based (VB) approach to 
correlate local lung dose and radiation-induced lung damage 
(RILD). 
 
Material and Methods: An inter-institutional database of 115 
Hodgkin lymphoma survivors treated with sequential chemo-
radiotherapy (with 18 RILD cases after treatment) were 
included in the study. Sixteen patients were excluded due to 
an inadequate CT coverage of the lungs. 
Each patient dataset was first normalized to a common 
template. Pre-registration steps were based on a binary mask 
extrapolated from the organ at risk segmentations of the 
treatment plan. For each patient, the mask, computed as the 
union and dilation (spherical structuring element of radius 30 
mm) of heart and lung structures, was used to crop the field-
of-view, allowing a coarse alignment of the structures of 
interest. CT images were masked accordingly in order to hide 
some anatomical inter-individual differences, and allowed 
the registration algorithm to work more efficiently on tissue 
contrast inside the chest. The median lung-volume patient 
was chosen as reference image in the non-rigid registration 
and a log-diffeomorphic approach [1] was used. The obtained 
deformation fields were then used to map the dose of each 
patient to the common coordinate system of the reference 
patient. 
A voxel-wise two-sample t-test was then performed on the 
normalized dose maps and statistically significance of the 
differences between groups was displayed as p-value map. 
 
Results: The robustness of co-registration process was 
assessed both by visual inspection (Fig. 1a-b) and by Dice 
scores for the lungs (Fig. 1c). On the whole population, the 
median Dice value was 0.94 (range: [0.87; 0.95]). As shown in 
